These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34808629)

  • 1. Thrombotic Microangiopathy Triggered by COVID-19: Case Reports.
    Korotchaeva J; Chebotareva N; Andreeva E; Sorokin Y; McDonnell V; Stolyarevich E; Moiseev S
    Nephron; 2022; 146(2):197-202. PubMed ID: 34808629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
    Fujita Y; Terashita M; Yazawa M; Yamasaki Y; Imamura T; Kibayashi J; Sawai T; Hidaka Y; Ohtani K; Inoue N; Shibagaki Y
    Intern Med; 2020; 59(1):93-99. PubMed ID: 31902910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis.
    Øzbay LA
    Clin J Gastroenterol; 2020 Jun; 13(3):344-348. PubMed ID: 31612381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
    Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
    Kello N; Khoury LE; Marder G; Furie R; Zapantis E; Horowitz DL
    Semin Arthritis Rheum; 2019 Aug; 49(1):74-83. PubMed ID: 30598332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.
    Jodele S; Dandoy CE; Danziger-Isakov L; Myers KC; El-Bietar J; Nelson A; Wallace G; Teusink-Cross A; Davies SM
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1337-1340. PubMed ID: 27060440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
    Wright RD; Bannerman F; Beresford MW; Oni L
    BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
    Boudhabhay I; Rabant M; Roumenina LT; Coupry LM; Poillerat V; Marchal A; Frémeaux-Bacchi V; El Karoui K; Monchi M; Pourcine F
    Front Immunol; 2021; 12():680567. PubMed ID: 34248962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARSCoV2 infection and multisystem inflammatory syndrome in children.
    Aurora T; Joseph N; Bhoopalan SV; Caniza MA; Flerlage T; Ghafoor S; Hankins J; Hijano DR; Jesudas R; Kirkham J; Martinez H; Alfaro GM; Sharma A; Hines M
    Haematologica; 2022 Oct; 107(10):2517-2522. PubMed ID: 35615927
    [No Abstract]   [Full Text] [Related]  

  • 11. Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation.
    Trujillo H; Huerta A; Alonso R; Serrano ML; Aguilar M; Morales E; Cavero T
    Clin Transplant; 2024 Sep; 38(9):e15443. PubMed ID: 39207183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-COVID-19 complement-mediated TMA: A case report.
    Jochims JA; Yazdani B; Krüger B; Popovic ZV; Krämer BK
    Clin Nephrol; 2024 Oct; 102(4):232-237. PubMed ID: 39045736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
    Guzzo G; Kissling S; Pantaleo G; Pascual M; Sadallah S; Teta D
    BMC Nephrol; 2021 Jul; 22(1):252. PubMed ID: 34229609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 associated thrombotic microangiopathy.
    Karabag Yilmaz E; Cebi MN; Karahan I; Saygılı S; Gulmez R; Demirgan EB; Durak C; Aygun F; Ozaltin F; Caliskan S; Canpolat N
    Nephrology (Carlton); 2023 Oct; 28(10):557-560. PubMed ID: 37485596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
    Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
    Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.
    Bjørkto MH; Barratt-Due A; Nordøy I; Dörje C; Galteland E; Lind A; Hilli A; Aukrust P; Mjøen G
    BMC Infect Dis; 2021 Feb; 21(1):137. PubMed ID: 33526010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
    J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    Pala C; Parenti E; Vizzini G; Gianfreda D; Rossi GM
    J Nephrol; 2024 May; 37(4):1141-1145. PubMed ID: 37847369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Response to Eculizumab in a Patient With COVID-19-Associated Acute Thrombotic Microangiopathy of the Allograft Kidney: A Case Report.
    Rehman S; de Mattos A; Stack M; Norman D; Zapata S; Wang PL; Mansoor AH; Kung V; Andeen NK
    Transplant Proc; 2023 Oct; 55(8):1866-1869. PubMed ID: 37105825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.